Evaluation of Thrombolytic Agents
- 1 January 1997
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 54 (Supplement) , 11-17
- https://doi.org/10.2165/00003495-199700543-00004
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Thrombolytic Therapy in the Treatment of StrokeDrugs, 1997
- Tissue Plasminogen ActivatorNew England Journal of Medicine, 1988
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinaseJournal of the American College of Cardiology, 1988
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Thrombolytic TherapyNew England Journal of Medicine, 1984
- Cloning and expression of human tissue-type plasminogen activator cDNA in E. coliNature, 1983
- Guidelines for the Use of Thrombolytic AgentsNew England Journal of Medicine, 1979
- Guidelines for thrombolytic therapy of deep-vein thrombosisProgress in Cardiovascular Diseases, 1979